Zomedica Corp.
ZOMDF
$0.05
$0.00142.88%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.83% | 14.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.83% | 14.12% | |||
| Cost of Revenue | 21.17% | 9.50% | |||
| Gross Profit | 9.64% | 16.00% | |||
| SG&A Expenses | 8.51% | -10.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.21% | -4.86% | |||
| Operating Income | -9.68% | 17.73% | |||
| Income Before Tax | -10.28% | 72.07% | |||
| Income Tax Expenses | -718.52% | 81.12% | |||
| Earnings from Continuing Operations | -7.42% | 72.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.42% | 72.02% | |||
| EBIT | -9.68% | 17.73% | |||
| EBITDA | -12.90% | 23.41% | |||
| EPS Basic | -7.35% | 72.13% | |||
| Normalized Basic EPS | -11.90% | 17.65% | |||
| EPS Diluted | -145.59% | 72.13% | |||
| Normalized Diluted EPS | -11.90% | 17.65% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||